| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Tract Infections | 13 | 2021 | 788 | 1.550 |
Why?
|
| Vesico-Ureteral Reflux | 10 | 2021 | 427 | 1.280 |
Why?
|
| Urinary Bladder | 8 | 2021 | 1172 | 0.660 |
Why?
|
| Urography | 2 | 2015 | 313 | 0.580 |
Why?
|
| Hypospadias | 3 | 2023 | 92 | 0.540 |
Why?
|
| Bladder Exstrophy | 3 | 2023 | 107 | 0.480 |
Why?
|
| Dog Diseases | 1 | 2013 | 138 | 0.420 |
Why?
|
| Autoantibodies | 4 | 2013 | 2035 | 0.410 |
Why?
|
| Cryptorchidism | 2 | 2023 | 125 | 0.400 |
Why?
|
| Circumcision, Male | 3 | 2023 | 150 | 0.400 |
Why?
|
| Hydronephrosis | 4 | 2019 | 269 | 0.370 |
Why?
|
| Cicatrix | 3 | 2020 | 764 | 0.350 |
Why?
|
| Optic Nerve | 1 | 2013 | 554 | 0.350 |
Why?
|
| Infertility, Male | 2 | 2023 | 409 | 0.290 |
Why?
|
| Urologic Surgical Procedures | 4 | 2020 | 302 | 0.280 |
Why?
|
| Radionuclide Imaging | 2 | 2021 | 2031 | 0.280 |
Why?
|
| Mass Screening | 5 | 2020 | 5255 | 0.270 |
Why?
|
| Protein Array Analysis | 4 | 2013 | 411 | 0.270 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2022 | 639 | 0.260 |
Why?
|
| Replantation | 2 | 2016 | 148 | 0.260 |
Why?
|
| Salmonella typhi | 3 | 2011 | 201 | 0.250 |
Why?
|
| Urologic Diseases | 2 | 2019 | 244 | 0.250 |
Why?
|
| Ureter | 2 | 2016 | 375 | 0.230 |
Why?
|
| Ureteroscopy | 3 | 2022 | 142 | 0.230 |
Why?
|
| Phimosis | 1 | 2023 | 10 | 0.230 |
Why?
|
| Glaucoma | 1 | 2013 | 1159 | 0.230 |
Why?
|
| Varicocele | 1 | 2023 | 78 | 0.220 |
Why?
|
| Lithotripsy, Laser | 1 | 2022 | 46 | 0.210 |
Why?
|
| Orchiectomy | 2 | 2021 | 474 | 0.200 |
Why?
|
| Kidney | 5 | 2021 | 7186 | 0.190 |
Why?
|
| Dilatation, Pathologic | 2 | 2019 | 520 | 0.190 |
Why?
|
| Urologic Surgical Procedures, Male | 2 | 2017 | 75 | 0.180 |
Why?
|
| Spermatic Cord Torsion | 1 | 2020 | 73 | 0.180 |
Why?
|
| Child, Preschool | 23 | 2021 | 41006 | 0.180 |
Why?
|
| Lasers, Solid-State | 1 | 2022 | 169 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 4462 | 0.180 |
Why?
|
| Infant | 20 | 2021 | 35136 | 0.180 |
Why?
|
| Typhoid Fever | 2 | 2011 | 197 | 0.170 |
Why?
|
| Child | 31 | 2023 | 77709 | 0.170 |
Why?
|
| Kidney Diseases | 2 | 2021 | 2149 | 0.170 |
Why?
|
| Cerebral Palsy | 1 | 2023 | 459 | 0.160 |
Why?
|
| Urinary Tract | 2 | 2019 | 309 | 0.160 |
Why?
|
| Hernia, Inguinal | 1 | 2020 | 210 | 0.160 |
Why?
|
| Keratin-5 | 1 | 2017 | 46 | 0.160 |
Why?
|
| Urethral Stricture | 1 | 2017 | 51 | 0.150 |
Why?
|
| Retrospective Studies | 26 | 2023 | 77449 | 0.150 |
Why?
|
| Fluoroscopy | 2 | 2018 | 924 | 0.150 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 270 | 0.150 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 458 | 0.150 |
Why?
|
| Male | 52 | 2023 | 350118 | 0.150 |
Why?
|
| Hospitals, Pediatric | 4 | 2021 | 1775 | 0.140 |
Why?
|
| Ultrasonography | 7 | 2021 | 5985 | 0.140 |
Why?
|
| Mood Disorders | 2 | 2013 | 1106 | 0.140 |
Why?
|
| Sacrococcygeal Region | 1 | 2016 | 52 | 0.140 |
Why?
|
| Sperm Retrieval | 1 | 2015 | 23 | 0.140 |
Why?
|
| Meningocele | 1 | 2016 | 45 | 0.130 |
Why?
|
| Postoperative Complications | 7 | 2023 | 15295 | 0.130 |
Why?
|
| Klinefelter Syndrome | 1 | 2015 | 48 | 0.130 |
Why?
|
| Urothelium | 1 | 2017 | 277 | 0.130 |
Why?
|
| Kidney Pelvis | 1 | 2016 | 188 | 0.130 |
Why?
|
| Cystostomy | 1 | 2015 | 26 | 0.130 |
Why?
|
| Bacteremia | 3 | 2011 | 962 | 0.130 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 804 | 0.130 |
Why?
|
| Anti-Allergic Agents | 1 | 2016 | 141 | 0.130 |
Why?
|
| Epidemiology | 1 | 2017 | 287 | 0.130 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2014 | 59 | 0.130 |
Why?
|
| Urinary Diversion | 1 | 2015 | 138 | 0.120 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2016 | 165 | 0.120 |
Why?
|
| Peanut Hypersensitivity | 1 | 2016 | 163 | 0.120 |
Why?
|
| Appendix | 1 | 2015 | 110 | 0.120 |
Why?
|
| Antigens, Bacterial | 2 | 2010 | 1171 | 0.120 |
Why?
|
| Sucrose | 1 | 2014 | 164 | 0.120 |
Why?
|
| Antibody Specificity | 2 | 2013 | 1095 | 0.120 |
Why?
|
| Humans | 69 | 2023 | 744343 | 0.120 |
Why?
|
| Siblings | 2 | 2015 | 854 | 0.110 |
Why?
|
| Proteomics | 5 | 2021 | 3638 | 0.110 |
Why?
|
| Costs and Cost Analysis | 2 | 2016 | 1681 | 0.110 |
Why?
|
| Urology | 1 | 2018 | 399 | 0.110 |
Why?
|
| Fever of Unknown Origin | 1 | 2013 | 93 | 0.110 |
Why?
|
| Female | 45 | 2021 | 380194 | 0.110 |
Why?
|
| Spinal Dysraphism | 1 | 2015 | 161 | 0.110 |
Why?
|
| Anaerobic Threshold | 1 | 2012 | 52 | 0.110 |
Why?
|
| Orchiopexy | 2 | 2023 | 20 | 0.110 |
Why?
|
| Infant, Newborn | 10 | 2020 | 25625 | 0.110 |
Why?
|
| RNA, Bacterial | 2 | 2011 | 390 | 0.110 |
Why?
|
| Adolescent | 23 | 2023 | 85781 | 0.110 |
Why?
|
| Urination | 3 | 2021 | 204 | 0.110 |
Why?
|
| Data Mining | 1 | 2017 | 537 | 0.110 |
Why?
|
| Cephalosporins | 1 | 2013 | 204 | 0.110 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2015 | 312 | 0.110 |
Why?
|
| Carbohydrates | 1 | 2014 | 394 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 1236 | 0.100 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2014 | 168 | 0.100 |
Why?
|
| Lumbosacral Region | 1 | 2013 | 310 | 0.100 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2014 | 625 | 0.100 |
Why?
|
| Cholera | 2 | 2009 | 785 | 0.100 |
Why?
|
| Diskectomy | 1 | 2013 | 206 | 0.100 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2015 | 360 | 0.100 |
Why?
|
| Desensitization, Immunologic | 1 | 2016 | 483 | 0.100 |
Why?
|
| Spondylolisthesis | 1 | 2013 | 163 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 1695 | 0.100 |
Why?
|
| Bangladesh | 5 | 2011 | 687 | 0.100 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 261 | 0.100 |
Why?
|
| Salmonella paratyphi A | 1 | 2010 | 47 | 0.100 |
Why?
|
| Paratyphoid Fever | 1 | 2010 | 35 | 0.100 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 2021 | 79 | 0.090 |
Why?
|
| Penis | 2 | 2023 | 216 | 0.090 |
Why?
|
| Ultrasonography, Mammary | 1 | 2012 | 250 | 0.090 |
Why?
|
| Recurrence | 5 | 2021 | 8340 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 687 | 0.090 |
Why?
|
| Proteome | 1 | 2020 | 1799 | 0.090 |
Why?
|
| Antibodies, Bacterial | 3 | 2010 | 1470 | 0.090 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2009 | 66 | 0.080 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2010 | 272 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 987 | 0.080 |
Why?
|
| Regeneration | 1 | 2017 | 1485 | 0.080 |
Why?
|
| Helminthiasis | 1 | 2009 | 66 | 0.080 |
Why?
|
| Medical Records | 1 | 2014 | 1413 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 1416 | 0.080 |
Why?
|
| Neutropenia | 1 | 2013 | 895 | 0.080 |
Why?
|
| Amino Acids | 1 | 2014 | 1736 | 0.080 |
Why?
|
| Blood | 1 | 2010 | 598 | 0.080 |
Why?
|
| Bacterial Proteins | 3 | 2011 | 3848 | 0.080 |
Why?
|
| Herpes Zoster | 1 | 2010 | 264 | 0.080 |
Why?
|
| Dogs | 1 | 2013 | 3912 | 0.080 |
Why?
|
| Documentation | 1 | 2014 | 871 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2018 | 1796 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2013 | 5179 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2011 | 3920 | 0.080 |
Why?
|
| Young Adult | 14 | 2021 | 56430 | 0.070 |
Why?
|
| Incidence | 5 | 2019 | 20947 | 0.070 |
Why?
|
| Health Resources | 1 | 2013 | 911 | 0.070 |
Why?
|
| Salmonella typhimurium | 1 | 2009 | 351 | 0.070 |
Why?
|
| Urine | 2 | 2020 | 370 | 0.070 |
Why?
|
| Colon | 1 | 2015 | 1772 | 0.070 |
Why?
|
| Antigens, Neoplasm | 3 | 2011 | 1988 | 0.070 |
Why?
|
| Clostridium Infections | 1 | 2013 | 548 | 0.070 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2009 | 404 | 0.070 |
Why?
|
| Antipsychotic Agents | 2 | 2012 | 3057 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2014 | 2017 | 0.070 |
Why?
|
| Gene Expression Profiling | 6 | 2014 | 9438 | 0.070 |
Why?
|
| Metabolome | 1 | 2012 | 895 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2017 | 3617 | 0.070 |
Why?
|
| Verbal Learning | 1 | 2008 | 467 | 0.070 |
Why?
|
| Telemedicine | 1 | 2023 | 2872 | 0.070 |
Why?
|
| Vibrio cholerae | 2 | 2009 | 806 | 0.070 |
Why?
|
| Risperidone | 1 | 2008 | 383 | 0.070 |
Why?
|
| Massachusetts | 2 | 2015 | 8663 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2013 | 3752 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2015 | 1859 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2015 | 2057 | 0.060 |
Why?
|
| Quality of Life | 2 | 2017 | 12804 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 2009 | 613 | 0.060 |
Why?
|
| Thiazoles | 1 | 2012 | 1483 | 0.060 |
Why?
|
| Poverty | 2 | 2013 | 2660 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 460 | 0.060 |
Why?
|
| Hematologic Neoplasms | 2 | 2013 | 1832 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 2455 | 0.060 |
Why?
|
| Spinal Fusion | 1 | 2013 | 1241 | 0.060 |
Why?
|
| Transplantation Conditioning | 1 | 2010 | 1598 | 0.060 |
Why?
|
| Breast | 1 | 2012 | 1969 | 0.060 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2009 | 1122 | 0.060 |
Why?
|
| Nicotine | 1 | 2008 | 681 | 0.060 |
Why?
|
| Breast Neoplasms | 4 | 2012 | 20822 | 0.060 |
Why?
|
| Observer Variation | 2 | 2019 | 2593 | 0.060 |
Why?
|
| Psychotic Disorders | 2 | 2008 | 3046 | 0.060 |
Why?
|
| Holmium | 1 | 2022 | 30 | 0.050 |
Why?
|
| Thulium | 1 | 2022 | 21 | 0.050 |
Why?
|
| Sperm Count | 1 | 2023 | 216 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15076 | 0.050 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2009 | 808 | 0.050 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 39050 | 0.050 |
Why?
|
| Double-Blind Method | 5 | 2019 | 12026 | 0.050 |
Why?
|
| Depressive Disorder, Major | 2 | 2012 | 4644 | 0.050 |
Why?
|
| Muscle Spasticity | 1 | 2023 | 154 | 0.050 |
Why?
|
| Sperm Motility | 1 | 2023 | 253 | 0.050 |
Why?
|
| Adult | 21 | 2018 | 214055 | 0.050 |
Why?
|
| Mental Recall | 1 | 2008 | 1205 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2009 | 1219 | 0.050 |
Why?
|
| Health Status | 1 | 2015 | 4034 | 0.050 |
Why?
|
| Semen Analysis | 1 | 2023 | 204 | 0.050 |
Why?
|
| Piperazines | 1 | 2012 | 2488 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 3616 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2015 | 3114 | 0.050 |
Why?
|
| Mammography | 1 | 2012 | 2476 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2942 | 0.050 |
Why?
|
| Semen | 1 | 2023 | 316 | 0.050 |
Why?
|
| Decision Making | 1 | 2015 | 3887 | 0.050 |
Why?
|
| Schizophrenic Psychology | 1 | 2008 | 1678 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2019 | 19905 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 7181 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 1177 | 0.050 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 2645 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.050 |
Why?
|
| Primary Health Care | 2 | 2013 | 4558 | 0.050 |
Why?
|
| Cohort Studies | 6 | 2022 | 40561 | 0.040 |
Why?
|
| Pelvic Pain | 1 | 2021 | 274 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3336 | 0.040 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 25043 | 0.040 |
Why?
|
| Bipolar Disorder | 2 | 2013 | 5027 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 14722 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2019 | 23338 | 0.040 |
Why?
|
| Registries | 1 | 2013 | 8089 | 0.040 |
Why?
|
| Sex Factors | 3 | 2019 | 10397 | 0.040 |
Why?
|
| Attention | 1 | 2008 | 2400 | 0.040 |
Why?
|
| Leukocytes | 1 | 2005 | 2043 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2015 | 12720 | 0.040 |
Why?
|
| Delayed Diagnosis | 1 | 2021 | 441 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2019 | 236 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4751 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 8949 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2020 | 5078 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 571 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 2245 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2017 | 145 | 0.030 |
Why?
|
| Immunoglobulin A | 2 | 2010 | 992 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2023 | 1002 | 0.030 |
Why?
|
| Microarray Analysis | 2 | 2010 | 767 | 0.030 |
Why?
|
| Syndrome | 1 | 2021 | 3251 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2023 | 1158 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2020 | 63114 | 0.030 |
Why?
|
| Time Factors | 4 | 2020 | 40075 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2020 | 8324 | 0.030 |
Why?
|
| United States | 6 | 2020 | 69872 | 0.030 |
Why?
|
| Middle Aged | 13 | 2015 | 213383 | 0.030 |
Why?
|
| Reoperation | 2 | 2015 | 4201 | 0.030 |
Why?
|
| Skin Tests | 1 | 2016 | 613 | 0.030 |
Why?
|
| Lung | 1 | 2013 | 9856 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 933 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2014 | 286 | 0.030 |
Why?
|
| Budesonide | 1 | 2014 | 154 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1616 | 0.030 |
Why?
|
| Peptides | 2 | 2020 | 4409 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 2400 | 0.030 |
Why?
|
| Chile | 1 | 2013 | 237 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2014 | 317 | 0.030 |
Why?
|
| Obesity | 1 | 2015 | 12745 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2015 | 9849 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 2018 | 903 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2014 | 390 | 0.030 |
Why?
|
| Gene Expression | 1 | 2005 | 7799 | 0.030 |
Why?
|
| Palpation | 1 | 2012 | 167 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2013 | 13033 | 0.030 |
Why?
|
| General Practitioners | 1 | 2013 | 103 | 0.030 |
Why?
|
| Animals | 6 | 2017 | 168757 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 987 | 0.030 |
Why?
|
| Organogenesis | 1 | 2013 | 222 | 0.020 |
Why?
|
| Pregnancy | 3 | 2019 | 29144 | 0.020 |
Why?
|
| Age Factors | 2 | 2019 | 18370 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 440 | 0.020 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2010 | 38 | 0.020 |
Why?
|
| Metaplasia | 1 | 2011 | 313 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 1198 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 1463 | 0.020 |
Why?
|
| Cell Count | 1 | 2014 | 1856 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 2959 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2013 | 812 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 2009 | 2216 | 0.020 |
Why?
|
| Length of Stay | 1 | 2023 | 6309 | 0.020 |
Why?
|
| Eosinophils | 1 | 2014 | 955 | 0.020 |
Why?
|
| Morbidity | 1 | 2015 | 1769 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 2010 | 204 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2008 | 6882 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35421 | 0.020 |
Why?
|
| Vidarabine | 1 | 2010 | 345 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2010 | 549 | 0.020 |
Why?
|
| Allergens | 1 | 2016 | 1320 | 0.020 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2010 | 195 | 0.020 |
Why?
|
| Reference Values | 1 | 2016 | 4982 | 0.020 |
Why?
|
| Neprilysin | 1 | 2011 | 439 | 0.020 |
Why?
|
| Virus Activation | 1 | 2010 | 319 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2017 | 2504 | 0.020 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2008 | 81 | 0.020 |
Why?
|
| Infertility | 1 | 2015 | 655 | 0.020 |
Why?
|
| Risk Factors | 4 | 2015 | 72290 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 2010 | 4560 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2021 | 6196 | 0.020 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2008 | 87 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2017 | 1880 | 0.020 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2008 | 150 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2925 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 2050 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 2009 | 403 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 215 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2008 | 552 | 0.020 |
Why?
|
| Epithelium | 1 | 2011 | 1679 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9146 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 2009 | 556 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2021 | 5102 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2008 | 711 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
| Inflammation | 1 | 2005 | 10638 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 2126 | 0.020 |
Why?
|
| Virulence | 1 | 2009 | 1333 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2010 | 1537 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2015 | 21746 | 0.020 |
Why?
|
| Mice | 4 | 2017 | 81183 | 0.020 |
Why?
|
| Species Specificity | 1 | 2009 | 2478 | 0.020 |
Why?
|
| Vitamin A | 1 | 2008 | 615 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 2242 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1790 | 0.020 |
Why?
|
| Boston | 1 | 2017 | 9313 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12354 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2008 | 968 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1572 | 0.010 |
Why?
|
| Cell Survival | 1 | 2014 | 5882 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2009 | 1057 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2009 | 1061 | 0.010 |
Why?
|
| Radiography | 1 | 2015 | 7023 | 0.010 |
Why?
|
| Zinc | 1 | 2008 | 684 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2916 | 0.010 |
Why?
|
| Long QT Syndrome | 1 | 2008 | 453 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 2203 | 0.010 |
Why?
|
| ROC Curve | 1 | 2010 | 3527 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 2029 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2008 | 2297 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2585 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 1086 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2716 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 7785 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 5391 | 0.010 |
Why?
|
| Arousal | 1 | 2008 | 1165 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5217 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 4776 | 0.010 |
Why?
|
| Age Distribution | 1 | 2008 | 2902 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12245 | 0.010 |
Why?
|
| Reaction Time | 1 | 2008 | 2097 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7149 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2008 | 1953 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 7729 | 0.010 |
Why?
|
| Prevalence | 1 | 2017 | 15226 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2010 | 6459 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3870 | 0.010 |
Why?
|
| Hospitals | 1 | 2014 | 3952 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11483 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2015 | 53288 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2015 | 3749 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4933 | 0.010 |
Why?
|
| Aged | 4 | 2013 | 163280 | 0.010 |
Why?
|
| Spleen | 1 | 2005 | 2362 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2011 | 3690 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6538 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10481 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 19229 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2010 | 2987 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2010 | 2957 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11031 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 4149 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 2948 | 0.010 |
Why?
|
| Exercise | 1 | 2012 | 5615 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 2749 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 3703 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 6993 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 12951 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 16365 | 0.010 |
Why?
|
| Depression | 1 | 2013 | 7766 | 0.010 |
Why?
|
| Logistic Models | 1 | 2008 | 13408 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9583 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29063 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 4838 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12261 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 21827 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 57776 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 17446 | 0.000 |
Why?
|
| Mutation | 1 | 2009 | 29786 | 0.000 |
Why?
|